Cartilage growth factor gains US patents:
This article was originally published in Clinica
ZymoGenetics has received two US patents covering a growth factor called Zfgf5, which could have a potential in the repair of damaged cartilage tissue. The patents relate to composition of matter for both nucleic acid and protein sequences of Zfgf5, also known in scientific literature as FGF18. These patents demonstrate the company's ability to turn sequence information into proprietary product candidates, says Seattle, Washington firm.
You may also be interested in...
As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.
By handing out free supplements to the clinically vulnerable, the UK government is effectively endorsing the use of vitamin D to reduce the risk and/or severity of COVID-19, although it says more research is needed.
A few months after bringing AstraZeneca onboard as a partner, the turnaround at the Alderley Park-based firm is moving ahead, buoyed by a fresh financing.